BIOMAT Database Logo BIOMAT Database Logo

[A report on the Spanish Registry of Patients with Alpha 1-Antitrypsin Deficiency. The Alpha 1-Antitrypsin Deficiency Study Group]. 1995

R Vidal, and M Miravitlles
Area de Trabajo IRTS (Insuficiencia Respiratoria y Trastornos del Sueño), Sociedad Española de Neumología y Cirugía Torácica.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001796 Blood Protein Disorders Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS. Blood Protein Disorder,Disorder, Blood Protein,Disorders, Blood Protein,Protein Disorder, Blood,Protein Disorders, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands

Related Publications

R Vidal, and M Miravitlles
A registry of patients with severe deficiency of alpha 1-antitrypsin. Design and methods. The Alpha 1-Antitrypsin Deficiency Registry Study Group.
October 1994, Chest,
R Vidal, and M Miravitlles
Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
December 1996, American journal of respiratory and critical care medicine,
R Vidal, and M Miravitlles
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group.
March 2000, American journal of respiratory and critical care medicine,
R Vidal, and M Miravitlles
Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis.
January 2017, Archivos de bronconeumologia,
R Vidal, and M Miravitlles
[Profiles of cases included in the Spanish registry of patients with alpha-1 antitrypsin deficiency].
April 2016, Anales de pediatria (Barcelona, Spain : 2003),
R Vidal, and M Miravitlles
Alpha-1 antitrypsin deficiency: a study from the registry.
December 2004, Human pathology,
R Vidal, and M Miravitlles
Alpha 1-antitrypsin deficiency registry.
May 1990, Chest,
R Vidal, and M Miravitlles
Alpha-1-antitrypsin deficiency registry.
December 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R Vidal, and M Miravitlles
Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group.
February 1997, Chest,
R Vidal, and M Miravitlles
Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.
July 1998, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!